Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
复制标题
DOI:
10.1016/j.ccr.2009.05.009
复制
发表时间:
2009-07-07
期刊:
影响因子:
50.3
通讯作者:
Cichowski K
中科院分区:
文献类型:
--
作者:
McGillicuddy LT;Fromm JA;Hollstein PE;Kubek S;Beroukhim R;De Raedt T;Johnson BW;Williams SM;Nghiemphu P;Liau LM;Cloughesy TF;Mischel PS;Parret A;Seiler J;Moldenhauer G;Scheffzek K;Stemmer-Rachamimov AO;Sawyers CL;Brennan C;Messiaen L;Mellinghoff IK;Cichowski K
Loss-of-function mutations in the NF1 tumor suppressor result in deregulated Ras signaling and drive tumorigenesis in the familial cancer syndrome neurofibromatosis type I. However, the extent to which NF1-inactivation promotes sporadic tumorigenesis is unknown. Here we report that NF1 is inactivated in sporadic gliomas via two mechanisms: excessive proteasomal degradation and genetic loss. NF1 protein destabilization is triggered by the hyperactivation of protein kinase C (PKC) and confers sensitivity to PKC inhibitors. However complete genetic loss, which only occurs when p53 is inactivated, mediates sensitivity to mTOR inhibitors. These studies reveal an expanding role for NF1-inactivation in sporadic gliomagenesis and illustrate how different mechanisms of inactivation are utilized in genetically distinct tumors, which consequently impacts therapeutic sensitivity. Tumor suppressors are often mutated in human cancer; however, the excessive proteasomal destruction of tumor suppressor proteins also promotes tumorigenesis. Here we show that the NF1 protein is destabilized in sporadic GBMs as a consequence of the hyperactivation of PKC. Notably, this destabilization confers sensitivity to PKC inhibitors. In contrast, a separate subset of GBMs that possess NF1 mutations are insensitive to PKC inhibitors but are sensitive to mTOR inhibitors. These findings reveal a broad role for NF1-inactivation in gliomagenesis and illustrate how different mechanisms of inactivation are utilized in the same tumor-type. Moreover they highlight the importance of elucidating the molecular mechanisms that underlie tumorigenesis, as such knowledge may be essential for developing personalized therapies.
登录
查看更多内容
影响因子:
64.5
作者:
LI, Y;BOLLAG, G;CAWTHON, R
通讯作者:
CAWTHON, R
影响因子:
15.8
作者:
Cloughesy, Tim F.;Yoshimoto, Koji;Nghiemphu, Phioanh;Brown, Kevin;Dang, Julie;Zhu, Shaojun;Hsueh, Teli;Chen, Yinan;Wang, Wei;Youngkin, David;Liau, Linda;Martin, Neil;Becker, Don;Bergsneider, Marvin;Lai, Albert;Green, Richard;Oglesby, Tom;Koleto, Michael;Trent, Jeff;Horvath, Steve;Mischel, Paul S.;Mellinghoff, Ingo K.;Sawyers, Charles L.
通讯作者:
Sawyers, Charles L.
DOI:
10.1073/pnas.92.20.9363
发表时间:
1995-09-26
影响因子:
11.1
作者:
DIMRI, GP;LEE, XH;CAMPISI, J
通讯作者:
CAMPISI, J
影响因子:
56.9
作者:
Marais, R;Light, Y;Marshall, CJ
通讯作者:
Marshall, CJ
影响因子:
64.5
作者:
CAWTHON, RM;WEISS, R;WHITE, R
通讯作者:
WHITE, R